SignalIndia
Laurus Labs share price at record high after Q2 results 2026, dividend announcement - Should you buy pharma stock?
Laurus Labs hit record high on Q2 results and dividend announcement.
Context
What happened: Laurus Labs shares rose nearly 6% to a record high of ₹2,381.15 after Q2 results showed revenue up 33% year-on-year and net profit more than doubling. The company announced an interim dividend of Re 1 per share.
Key numbers: Q2FY27 revenue ₹2,206 crore versus ₹1,653 crore; net profit ₹441 crore versus ₹195 crore; EBITDA ₹762 crore versus ₹429 crore; EBITDA margin 34.5%;
Why it matters: Brokerages differed on valuation. Jefferies kept HOLD and raised its target, while Kotak kept SELL despite expecting EBITDA CAGR of around 34% over FY26 to FY29, flagging valuation concerns.
Coverage: 3 outlets in 24h
What changed
Laurus Labs shares rose nearly 6% to a record high of ₹2,381.15 after Q2 results showed revenue up 33% year-on-year and net profit more than doubling. The company announced an interim dividend of Re 1 per share.
Why it matters
Brokerages differed on valuation. Jefferies kept HOLD and raised its target, while Kotak kept SELL despite expecting EBITDA CAGR of around 34% over FY26 to FY29, flagging valuation concerns.